Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank Disease ID
1 ADORA1 [1] Sphingolipid signaling pathway D00045 Adenosine [3] 13, 58, 65
2 ADORA1 [1] Sphingolipid signaling pathway D00227 Aminophylline [1] 63
3 ADORA1 [1] Sphingolipid signaling pathway D00371 Theophylline [2] 236, 299
4 ADORA1 [1] Sphingolipid signaling pathway D00528 Caffeine [9] 2, 6, 13, 21, 46, 78, 96, 97, 265
5 ADORA1 [1] Sphingolipid signaling pathway D01453 Caffeine [9] 2, 6, 13, 21, 46, 78, 96, 97, 265
6 ADORA1 [1] Sphingolipid signaling pathway D01712 Theophylline [2] 236, 299
7 ADORA1 [1] Sphingolipid signaling pathway D02017 Theophylline [2] 236, 299
8 ADORA1 [1] Sphingolipid signaling pathway D02769 Adenosine phosphate [1] 46
9 ADORA1 [1] Sphingolipid signaling pathway D05429 Aminophylline [1] 63
10 ADORA1 [1] Sphingolipid signaling pathway D06103 Theophylline [2] 236, 299
11 ADORA1 [1] Sphingolipid signaling pathway D06104 Theophylline [2] 236, 299
12 ADORA3 [1] Sphingolipid signaling pathway D00045 Adenosine [3] 13, 58, 65
13 ADORA3 [1] Sphingolipid signaling pathway D02769 Adenosine phosphate [1] 46
14 ADORA3 [1] Sphingolipid signaling pathway D10971 Piclidenoson [1] 46
15 MAPK14 [11] Sphingolipid signaling pathway, VEGF signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod [2] 113, 222
16 MAPK14 [11] Sphingolipid signaling pathway, VEGF signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod [1] 8
17 S1PR1 [1] Sphingolipid signaling pathway D10001 Fingolimod [3] 13, 14, 156
18 S1PR1 [1] Sphingolipid signaling pathway D10930 Etrasimod [3] 96, 97, 98
19 S1PR1 [1] Sphingolipid signaling pathway D10968 Ozanimod [3] 13, 96, 97
20 S1PR1 [1] Sphingolipid signaling pathway D11215 Ponesimod [1] 13
21 S1PR1 [1] Sphingolipid signaling pathway D11283 Cenerimod [1] 49
22 S1PR1 [1] Sphingolipid signaling pathway D11460 Siponimod [2] 13, 50
23 S1PR3 [1] Sphingolipid signaling pathway D10930 Etrasimod [3] 96, 97, 98
24 S1PR3 [1] Sphingolipid signaling pathway D10968 Ozanimod [3] 13, 96, 97
25 FCER1A [1] Sphingolipid signaling pathway D05251 Omalizumab [7] 46, 53, 65, 98, 162, 226, 299
26 FYN [3] Sphingolipid signaling pathway, T cell receptor signaling pathway, Viral myocarditis D03658 Dasatinib [2] 51, 85
27 FYN [3] Sphingolipid signaling pathway, T cell receptor signaling pathway, Viral myocarditis D06414 Dasatinib [2] 51, 85
28 MAP3K5 [5] Sphingolipid signaling pathway, Tight junction, TNF signaling pathway, Thermogenesis, Spinocerebellar ataxia D10988 Selonsertib [1] 86
29 NFKB1 [11] Sphingolipid signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis D01146 Iguratimod [4] 46, 51, 53, 271
30 OPRD1 [1] Sphingolipid signaling pathway D00729 Loperamide [2] 13, 97
31 OPRD1 [1] Sphingolipid signaling pathway D00843 Nalbuphine [1] 85
32 OPRD1 [1] Sphingolipid signaling pathway D01340 Naloxone [2] 6, 226
33 OPRD1 [1] Sphingolipid signaling pathway D02095 Naltrexone [13] 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226
34 OPRD1 [1] Sphingolipid signaling pathway D03783 Oxycodone [7] 6, 13, 46, 70, 226, 231, 298
35 OPRD1 [1] Sphingolipid signaling pathway D05111 Nalmefene [1] 6
36 OPRD1 [1] Sphingolipid signaling pathway D05113 Naltrexone [13] 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226
37 OPRD1 [1] Sphingolipid signaling pathway D05312 Oxycodone [7] 6, 13, 46, 70, 226, 231, 298
38 OPRD1 [1] Sphingolipid signaling pathway D05462 Oxycodone [7] 6, 13, 46, 70, 226, 231, 298
39 OPRD1 [1] Sphingolipid signaling pathway D07113 Loperamide [2] 13, 97
40 OPRD1 [1] Sphingolipid signaling pathway D08144 Loperamide [2] 13, 97
41 OPRD1 [1] Sphingolipid signaling pathway D08246 Nalbuphine [1] 85
42 OPRD1 [1] Sphingolipid signaling pathway D08249 Naloxone [2] 6, 226
43 PIK3CA [10] Sphingolipid signaling pathway, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Yersinia infection, Viral carcinogenesis D11158 Leniolisib [2] 53, 65
44 PIK3CB [10] Sphingolipid signaling pathway, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Yersinia infection, Viral carcinogenesis D11158 Leniolisib [2] 53, 65
45 PIK3CD [10] Sphingolipid signaling pathway, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Yersinia infection, Viral carcinogenesis D11158 Leniolisib [2] 53, 65
46 PIK3CD [10] Sphingolipid signaling pathway, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Yersinia infection, Viral carcinogenesis D11437 Parsaclisib [3] 35, 53, 61
47 S1PR5 [1] Sphingolipid signaling pathway D10930 Etrasimod [3] 96, 97, 98
48 S1PR5 [1] Sphingolipid signaling pathway D10968 Ozanimod [3] 13, 96, 97
49 S1PR5 [1] Sphingolipid signaling pathway D11460 Siponimod [2] 13, 50
50 PRKCE [4] Sphingolipid signaling pathway, Vascular smooth muscle contraction, Tight junction, Type II diabetes mellitus D09671 Sotrastaurin [1] 97
51 MAPK11 [11] Sphingolipid signaling pathway, VEGF signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod [2] 113, 222
52 MAPK11 [11] Sphingolipid signaling pathway, VEGF signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod [1] 8
53 MAPK13 [11] Sphingolipid signaling pathway, VEGF signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod [2] 113, 222
54 MAPK13 [11] Sphingolipid signaling pathway, VEGF signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod [1] 8
55 MAP2K1 [9] Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer D09666 Selumetinib [1] 34
56 MAP2K1 [9] Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer D10175 Trametinib [4] 2, 34, 279, 280
57 MAP2K1 [9] Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer D10405 Cobimetinib [1] 280
58 MAP2K1 [9] Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer D10604 Binimetinib [1] 34
59 MAP2K2 [8] Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer D09666 Selumetinib [1] 34
60 MAP2K2 [8] Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer D10175 Trametinib [4] 2, 34, 279, 280
61 MAP2K2 [8] Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer D10405 Cobimetinib [1] 280
62 MAP2K2 [8] Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Yersinia infection, Thyroid cancer D10604 Binimetinib [1] 34
63 RAF1 [6] Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Tuberculosis D06272 Sorafenib [2] 34, 86
64 RAF1 [6] Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Tuberculosis D08524 Sorafenib [2] 34, 86
65 BCL2 [3] Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis D10679 Venetoclax [1] 28
66 RELA [11] Sphingolipid signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis D12181 Edasalonexent [1] 113
67 ROCK1 [5] Sphingolipid signaling pathway, Vascular smooth muscle contraction, TGF-beta signaling pathway, Tight junction, Yersinia infection D07941 Fasudil [4] 2, 5, 7, 51
68 MAPK12 [11] Sphingolipid signaling pathway, VEGF signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod [2] 113, 222
69 MAPK12 [11] Sphingolipid signaling pathway, VEGF signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod [1] 8
70 SMPD1 [1] Sphingolipid signaling pathway D10820 Olipudase alfa [1] 19
71 TNF [12] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus D00742 Etanercept [17] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285, 298
72 TNF [12] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus D00754 Thalidomide [20] 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331
73 TNF [12] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus D01583 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
74 TNF [12] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus D02597 Adalimumab [18] 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 151, 160, 164, 222, 226, 269, 270, 271
75 TNF [12] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus D02598 Infliximab [27] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271
76 TNF [12] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus D03441 Certolizumab pegol [8] 37, 46, 49, 96, 97, 107, 226, 271
77 TNF [12] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus D04358 Golimumab [8] 46, 56, 84, 96, 97, 107, 270, 271
78 TNF [12] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus D04687 Lenalidomide [8] 16, 26, 28, 34, 49, 284, 300, 331
79 TNF [12] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus D05393 Pegsunercept [1] 46
80 TNF [12] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus D08976 Pomalidomide [6] 28, 34, 51, 85, 227, 331
81 TNF [12] Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus D09944 Ozoralizumab [1] 46
82 S1PR4 [1] Sphingolipid signaling pathway D10930 Etrasimod [3] 96, 97, 98
83 S1PR4 [1] Sphingolipid signaling pathway D10968 Ozanimod [3] 13, 96, 97
84 S1PR2 [1] Sphingolipid signaling pathway D10930 Etrasimod [3] 96, 97, 98
85 S1PR2 [1] Sphingolipid signaling pathway D10968 Ozanimod [3] 13, 96, 97
86 ROCK2 [5] Sphingolipid signaling pathway, Vascular smooth muscle contraction, Wnt signaling pathway, Tight junction, Yersinia infection D07941 Fasudil [4] 2, 5, 7, 51
87 ROCK2 [5] Sphingolipid signaling pathway, Vascular smooth muscle contraction, Wnt signaling pathway, Tight junction, Yersinia infection D11815 Belumosudil [1] 51